Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4062683 | 0.95 | GPR119 (0.55) | GPR119KDM4EPKMSLC6A2SLC6A4 | |
| SCHEMBL4063161 | 0.90 | GPR119 (0.52) | GPR119KDM4EPKM | |
| SCHEMBL4059662 | 0.90 | GPR119 (0.53) | GPR119KDM4EPKMSLC6A2SLC6A4 | |
| SCHEMBL3600086 | 0.87 | SLC6A2 (0.47) | GPR119SLC6A2SLC6A4 | |
| SCHEMBL4062687 | 0.85 | GPR119 (0.55) | GPR119KDM4EPKM | |
| SCHEMBL3605054 | 0.85 | SLC6A2 (0.55) | GPR119SLC6A2SLC6A4 | |
| SCHEMBL4058421 | 0.85 | SLC6A2 (0.48) | GPR119SLC6A2SLC6A4 | |
| SCHEMBL3605455 | 0.83 | SLC6A2 (0.44) | GPR119SLC6A2SLC6A4 | |
| SCHEMBL3600866 | 0.83 | SLC6A2 (0.48) | GPR119KDM4EPKMSLC6A2SLC6A4 | |
| SCHEMBL4063277 | 0.83 | GPR119 (0.48) | GPR119KDM4EPKMSLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2061776-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | Wyeth a Corporation of the State of Delaware (US) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008073459-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-06-19 | — | — | WO | disclosed |